COVID-19

Category: Health

CSL received approval from Japan's MHLW for ARCT-154, a self-amplifying mRNA COVID-19 vaccine for adults, enhancing its portfolio of vaccines against respiratory viral diseases.

Keywords: COVID-19, mRNA vaccine, CSL

Source: CSL Limited

Update At: 7/24/2024

Related Sources